⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 1, 2013Alternatives to Laboratory Animals

Why Animal Studies are Still Being Used in Drug Development

Marlous Kooijman

View at Publisher

Ask AI

Bookmark

Share

Abstract

The lack of success of the implementation of new methods in drug development can be studied from an innovation perspective

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marlous Kooijman (2013) studied this question.

synapsesocial.com/papers/6a1bd854ea84844e355f106a https://doi.org/10.1177/026119291304100627

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Managing the Rivalry of Competing Institutional LogicsOriginal Research · 2009 · 1,819 citations
2AI-integrated human-relevant alternatives to animal experimentation in drug development: Toward a predictive translational ecosystem, from in vitro and in silico models to clinical and real-world evidenceAlternatives to Laboratory Animals · Fri,
3Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease modelsAlternatives to Laboratory Animals · Fri,
4Beyond rodents: A systematic review of antidepressant-like effects in Drosophila melanogaster as an alternative model in psychopharmacologyAlternatives to Laboratory Animals · Fri,
5Frustra laborare ? Methodological inefficiencies and epistemic limits in toxicological testingAlternatives to Laboratory Animals · Tue,

More from Alternatives to Laboratory Animals

Advancing New Approach Methodologies (NAMs) through the publication of negative resultsWed,
Spotlight on Three Rs ProgressFri,
Galleria mellonella as an invertebrate screening model for biocompatibility and in vivo functionality testing of imaging contrast agentsThu,
Data-driven science, ethics and risk: Building knowledge of key ethics–risk intersections relevant to public sector decision-makingMon,
Replacing immunisation-dependent antibody reagent production: Challenges under the UK Replacing Animals in Science 2025 strategySat,